Department of Cardiovascular Medicine, Kyoto University Graduate School of Medicine, Kyoto, Japan.
Department of Clinical Epidemiology, Hyogo College of Medicine, Nishinomiya, Japan.
J Am Coll Cardiol. 2015 Dec 29;66(25):2827-2838. doi: 10.1016/j.jacc.2015.10.001. Epub 2015 Oct 15.
BACKGROUND: Current guidelines generally recommend watchful waiting until symptoms emerge for aortic valve replacement (AVR) in asymptomatic patients with severe aortic stenosis (AS). OBJECTIVES: The study sought to compare the long-term outcomes of initial AVR versus conservative strategies following the diagnosis of asymptomatic severe AS. METHODS: We used data from a large multicenter registry enrolling 3,815 consecutive patients with severe AS (peak aortic jet velocity >4.0 m/s, or mean aortic pressure gradient >40 mm Hg, or aortic valve area <1.0 cm(2)) between January 2003 and December 2011. Among 1,808 asymptomatic patients, the initial AVR and conservative strategies were chosen in 291 patients, and 1,517 patients, respectively. Median follow-up was 1,361 days with 90% follow-up rate at 2 years. The propensity score-matched cohort of 582 patients (n = 291 in each group) was developed as the main analysis set for the current report. RESULTS: Baseline characteristics of the propensity score-matched cohort were largely comparable, except for the slightly younger age and the greater AS severity in the initial AVR group. In the conservative group, AVR was performed in 41% of patients during follow-up. The cumulative 5-year incidences of all-cause death and heart failure hospitalization were significantly lower in the initial AVR group than in the conservative group (15.4% vs. 26.4%, p = 0.009; 3.8% vs. 19.9%, p < 0.001, respectively). CONCLUSIONS: The long-term outcome of asymptomatic patients with severe AS was dismal when managed conservatively in this real-world analysis and might be substantially improved by an initial AVR strategy. (Contemporary Outcomes After Surgery and Medical Treatment in Patients With Severe Aortic Stenosis Registry; UMIN000012140).
背景:目前的指南通常建议对无症状的重度主动脉瓣狭窄(AS)患者进行主动脉瓣置换术(AVR)时,等待症状出现。
目的:本研究旨在比较无症状重度 AS 患者初始 AVR 与保守治疗策略的长期结果。
方法:我们使用了一个大型多中心注册中心的数据,该中心于 2003 年 1 月至 2011 年 12 月间连续招募了 3815 例重度 AS 患者(峰值主动脉射流速度>4.0m/s,或平均主动脉压力梯度>40mmHg,或主动脉瓣口面积<1.0cm²)。在 1808 例无症状患者中,291 例患者选择初始 AVR,1517 例患者选择保守治疗策略。中位随访时间为 1361 天,2 年时的随访率为 90%。582 例患者的倾向评分匹配队列(每组 291 例)作为本报告的主要分析集。
结果:倾向评分匹配队列的基线特征基本相似,除了初始 AVR 组的年龄稍轻和 AS 严重程度稍高。在保守组中,41%的患者在随访期间接受了 AVR。初始 AVR 组的全因死亡和心力衰竭住院的累积 5 年发生率明显低于保守组(15.4%比 26.4%,p=0.009;3.8%比 19.9%,p<0.001)。
结论:在这项真实世界分析中,对无症状重度 AS 患者进行保守治疗的长期预后较差,初始 AVR 策略可能会显著改善预后。(重度主动脉瓣狭窄患者手术后和药物治疗的当代结局注册研究;UMIN000012140)。
J Am Coll Cardiol. 2015-10-15
Dan Med J. 2017-5
Front Endocrinol (Lausanne). 2025-7-30
Eur Heart J Digit Health. 2025-7-1
BMC Cardiovasc Disord. 2025-7-4
J Am Heart Assoc. 2025-1-7